
Gastric bypass at MedProper Istanbul from £2,695 all-inclusive. Roux-en-Y and mini bypass. JCI hospital, IFSO surgeons, 12-month aftercare.
Güvenli mi?
Hastanemiz, dünya standartlarında JCI akreditasyonuna sahiptir. Uluslararası hasta güvenliği TEMOS tarafından doğrulanmıştır.
Tedavi süreci nasıl işler?
Tüm detaylar tedavi öncesinde netleştirilir. Ameliyat, hastane, konaklama, transfer ve takip süreci hakkında bilgi alabilirsiniz.
Bir sorun olursa ne olur?
Türk Sağlık Bakanlığı mevzuatı gereği zorunlu komplikasyon sigortası mevcuttur. Revizyon gerekirse tüm süreç kapsam dahilindedir.
Cerrahım kim?
Cerrahınız önceden belirlenir. Uzmanlık alanı, deneyimi ve yetkinlikleri sizinle paylaşılır.
Eve döndükten sonra ne olur?
7/24 WhatsApp ile koordinatörünüze ulaşabilirsiniz. Cerrahınızla planlı video kontrolleri yapılır. 12 ay boyunca takip edilirsiniz.
Gastric bypass surgery, formally known as Roux-en-Y gastric bypass (RYGB), is the gold standard of metabolic surgery and one of the most thoroughly studied surgical procedures in medicine. During the operation, the surgeon creates a small stomach pouch of approximately 30 ml — roughly the size of an egg — and reroutes the small intestine to connect directly to this pouch, bypassing the majority of the stomach and the first section of the small intestine (the duodenum).
This dual mechanism — restriction (smaller stomach) plus controlled malabsorption (bypassed intestine) — produces greater average weight loss than gastric sleeve and the highest rates of Type 2 diabetes remission among all bariatric procedures. First performed in 1967 and performed laparoscopically since the mid-1990s, Roux-en-Y gastric bypass has the longest track record of any modern bariatric procedure.
At MedProper Istanbul, gastric bypass is performed laparoscopically through 5 small incisions by IFSO-member bariatric surgeons in a JCI-accredited hospital, with all-inclusive packages starting from £2,695 / €3,150.
| Procedure | MedProper (GBP) | MedProper (EUR) | UK Private | USA Private | You Save |
|---|---|---|---|---|---|
| Gastric Bypass (Roux-en-Y) | from £2,695 | from €3,150 | £8,000-£12,000 | $20,000-$35,000 |
Size özel tedavi planı ve süreç bilgisi alın. Herhangi bir taahhüt gerektirmez.
| up to 90% |
| Mini Gastric Bypass (OAGB) | from £2,695 | from €3,150 | £8,000-£12,000 | $20,000-$35,000 | up to 90% |
| Cost Component | MedProper Istanbul | UK Private Clinic | USA Private Clinic |
|---|---|---|---|
| Surgeon fee | Included | £4,000-£6,000 | $10,000-$18,000 |
| Operating facility + theatre | Included | £1,500-£2,500 | $3,000-£5,000 |
| Anaesthesia (general) | Included | £500-£1,000 | $1,000-$2,000 |
| Hospital stay (3-5 nights) | Included | £500-£1,000/night | $1,000-$2,000/night |
| Hotel (3-5 nights, 4-5 star) | Included | N/A | N/A |
| VIP airport transfers | Included | N/A | N/A |
| Pre-operative blood work + imaging | Included | £200-£400 | $500-$1,000 |
| Post-operative medications | Included | £50-£150 | $100-$300 |
| Vitamin supplements (3 months) | Included | £30-£60 | $50-$100 |
| Dietitian consultation | Included | £100-£250/visit | $200-$400/visit |
| Leak test (contrast swallow) | Included | Varies | Varies |
| 12-month aftercare | Included | £100-£250/visit | $200-$400/visit |
| Total | from £2,695 | £7,500-£13,000+ | $16,000-$30,000+ |
The classic gastric bypass technique, performed since 1967. The surgeon creates two anastomoses (connections): one between the small stomach pouch and the Roux limb of the jejunum (~150 cm), and a second Y-connection where the biliopancreatic limb rejoins. This creates separate pathways for food and digestive enzymes, combining restriction with controlled malabsorption.
A simplified version of Roux-en-Y with a single intestinal connection instead of two. Creates a longer, tubular stomach pouch connected to a loop of small intestine approximately 200 cm from the ligament of Treitz. Now representing approximately 30% of all bypass procedures globally and growing in popularity.
This is the most common question patients ask. The answer depends on your BMI, health conditions, and specific goals:
| Criteria | Gastric Bypass (Roux-en-Y) | Gastric Sleeve |
|---|---|---|
| How it works | Small pouch (~30 ml) + intestine rerouted | 75-80% of stomach removed |
| Duration | 90-150 minutes | 45-75 minutes |
| Hospital stay | 3-5 nights | 2-4 nights |
| Weight loss (12-18 months) | 65-75% excess weight | 60-70% excess weight |
| Type 2 diabetes remission | 80%+ (superior) | ~60% |
| Acid reflux (GORD) | Resolves in 90%+ | May worsen (15-20%) |
| Dumping syndrome | 10-15% (discourages sugar) | Rare |
| Lifetime supplements | Required (B12, iron, calcium, multivitamin) | Recommended (multivitamin) |
| Reversibility | Technically reversible, rarely performed | Irreversible |
| MedProper price | from £2,695 | from £1,925 |
| Best for | BMI 45+, T2 diabetes, chronic GORD | BMI 35-45, no severe reflux |
MedProper recommendation: Gastric sleeve is optimal for most patients (BMI 35-45 without severe reflux) due to simpler surgery, faster recovery, and lower supplement requirements. Gastric bypass is specifically recommended when the patient has BMI over 45, poorly controlled Type 2 diabetes, chronic acid reflux, or a sweet-eating pattern (bypass creates dumping syndrome which discourages sugar consumption).
Gastric bypass is the recommended procedure when:
Total duration: 90-150 minutes. The procedure is performed entirely laparoscopically — no large incisions.
The mortality rate for laparoscopic Roux-en-Y gastric bypass at experienced, high-volume centres is approximately 0.2-0.5% — slightly higher than gastric sleeve (0.08-0.19%) due to the greater surgical complexity (two anastomoses versus none). At JCI-accredited hospitals with standardised protocols, the rate is at the lower end of this range.
For perspective: the long-term mortality risk of untreated severe obesity far exceeds the surgical risk. Bariatric surgery reduces all-cause mortality by 50-70% over 10 years (Lancet, 2024).
| Complication | Frequency | MedProper Management |
|---|---|---|
| Anastomotic leak | <2% | Dual leak test protocol |
| Internal hernia | 1-3% (long-term) | Mesenteric defect closure during surgery |
| Marginal ulcer | 5-10% | Treatable with PPI medication |
| Dumping syndrome | 10-15% | Dietary management (usually resolves) |
| Nutritional deficiency | Ongoing risk | Mandatory supplement protocol + monitoring |
| Bleeding | <1% | 24-hour monitoring + Level 3 ICU on-site |
| DVT/PE | <1% | Prophylactic DVT protocol |
| Phase | Timeline | What to Expect |
|---|---|---|
| Hospital | Days 1-4 | Clear liquids, mobilisation, leak test, pain management |
| Hotel recovery | Days 5-7 | Full liquids (protein shakes), rest, dietary guidance |
| Home: liquids | Weeks 1-2 | Protein shakes, smooth soups, 60g protein/day target |
| Pureed foods | Weeks 3-4 | Blended vegetables, hummus, scrambled egg |
| Soft foods | Weeks 5-6 | Soft fish, cottage cheese, mashed vegetables |
| Normal diet | Week 7+ | Small portions, protein first, chew thoroughly |
| Return to desk work | 2-3 weeks | Light activity, no heavy lifting |
| Return to exercise | 4-6 weeks | Walking from day 1, moderate exercise from week 4 |
| Full recovery | 6-8 weeks | All normal activities resumed |
After gastric bypass, you must take the following supplements for life:
MedProper provides 3 months of supplements and a detailed protocol for your GP. Blood work should be checked at 6 weeks, 3 months, 6 months, and annually thereafter.
| Factor | GLP-1 Medications (Ozempic/Wegovy) | Gastric Bypass |
|---|---|---|
| Weight loss | 15-20% of total body weight | 30-35% of total body weight |
| Type 2 diabetes | Improvement | 80%+ full remission |
| Duration | Must take indefinitely | One-time procedure |
| Monthly cost (UK) | £200-£300/month ongoing | One-time from £2,695 |
| 5-year cost (UK) | £12,000-£18,000 | £2,695 (one-time) |
| Weight regain on stopping | 60-70% within 12 months | 10-15% at 5 years |
| GORD effect | Neutral | Resolves 90%+ |
| Best for | BMI 27-35, medication-responsive | BMI 35+, lasting results, diabetes |
Surgery is more cost-effective, produces greater weight loss, superior diabetes remission, and does not require lifelong medication. Some patients use GLP-1 agonists as a bridge to surgery or as post-surgical support for stubborn plateaus.